Targeting Glutathione-S transferase enzymes in musculoskeletal sarcomas: A promising therapeutic strategy

Michela Pasello, Maria Cristina Manara, Francesca Michelacci, Marilù Fanelli, Claudia Maria Hattinger, Giordano Nicoletti, Lorena Landuzzi, Pier Luigi Lollini, Annamaria Caccuri, Piero Picci, Katia Scotlandi, Massimo Serra

Research output: Contribution to journalArticle

Abstract

Recent studies have indicated that targeting glutathione-S-transferase (GST) isoenzymes may be a promising novel strategy to improve the efficacy of conventional chemotherapy in the three most common musculoskeletal tumours: osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma. By using a panel of 15 drug-sensitive and drug-resistant human osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma cell lines, the efficay of the GST-targeting agent 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) has been assessed and related to GST isoenzymes expression (namely GSTP1, GSTA1, GSTM1, and MGST). NBDHEX showed a relevant in vitro activity on all cell lines, including the drug-resistant ones and those with higher GSTs levels. The in vitro activity of NBDHEX was mostly related to cytostatic effects, with a less evident apoptotic induction. NBDHEX positively interacted with doxorubicin, vincristine, cisplatin but showed antagonistic effects with methotrexate. In vivo studies confirmed the cytostatic efficay of NBDHEX and its positive interaction with vincristine in Ewing's sarcoma cells, and also indicated a positive effect against the metastatisation of osteosarcoma cells. The whole body of evidence found in this study indicated that targeting GSTs in osteosarcoma, Ewing's sarcoma and rhabdomyosarcoma may be an interesting new therapeutic option, which can be considered for patients who are scarcely responsive to conventional regimens.

Original languageEnglish
Pages (from-to)131-145
Number of pages15
JournalAnalytical Cellular Pathology
Volume34
Issue number3
DOIs
Publication statusPublished - 2011

Fingerprint

Hexanols
Ewing's Sarcoma
Osteosarcoma
Glutathione Transferase
Sarcoma
Rhabdomyosarcoma
Cytostatic Agents
Vincristine
Enzymes
Isoenzymes
Pharmaceutical Preparations
Cell Line
Therapeutics
Methotrexate
Doxorubicin
Cisplatin
Drug Therapy
In Vitro Techniques

Keywords

  • glutathione metabolism
  • Musculoskeletal sarcomas
  • novel antitumour agents
  • target therapies

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Medicine
  • Pathology and Forensic Medicine
  • Cell Biology

Cite this

Targeting Glutathione-S transferase enzymes in musculoskeletal sarcomas : A promising therapeutic strategy. / Pasello, Michela; Manara, Maria Cristina; Michelacci, Francesca; Fanelli, Marilù; Hattinger, Claudia Maria; Nicoletti, Giordano; Landuzzi, Lorena; Lollini, Pier Luigi; Caccuri, Annamaria; Picci, Piero; Scotlandi, Katia; Serra, Massimo.

In: Analytical Cellular Pathology, Vol. 34, No. 3, 2011, p. 131-145.

Research output: Contribution to journalArticle

@article{5055e60d362b4f4faa61ff9ea33b5e9a,
title = "Targeting Glutathione-S transferase enzymes in musculoskeletal sarcomas: A promising therapeutic strategy",
abstract = "Recent studies have indicated that targeting glutathione-S-transferase (GST) isoenzymes may be a promising novel strategy to improve the efficacy of conventional chemotherapy in the three most common musculoskeletal tumours: osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma. By using a panel of 15 drug-sensitive and drug-resistant human osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma cell lines, the efficay of the GST-targeting agent 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) has been assessed and related to GST isoenzymes expression (namely GSTP1, GSTA1, GSTM1, and MGST). NBDHEX showed a relevant in vitro activity on all cell lines, including the drug-resistant ones and those with higher GSTs levels. The in vitro activity of NBDHEX was mostly related to cytostatic effects, with a less evident apoptotic induction. NBDHEX positively interacted with doxorubicin, vincristine, cisplatin but showed antagonistic effects with methotrexate. In vivo studies confirmed the cytostatic efficay of NBDHEX and its positive interaction with vincristine in Ewing's sarcoma cells, and also indicated a positive effect against the metastatisation of osteosarcoma cells. The whole body of evidence found in this study indicated that targeting GSTs in osteosarcoma, Ewing's sarcoma and rhabdomyosarcoma may be an interesting new therapeutic option, which can be considered for patients who are scarcely responsive to conventional regimens.",
keywords = "glutathione metabolism, Musculoskeletal sarcomas, novel antitumour agents, target therapies",
author = "Michela Pasello and Manara, {Maria Cristina} and Francesca Michelacci and Maril{\`u} Fanelli and Hattinger, {Claudia Maria} and Giordano Nicoletti and Lorena Landuzzi and Lollini, {Pier Luigi} and Annamaria Caccuri and Piero Picci and Katia Scotlandi and Massimo Serra",
year = "2011",
doi = "10.3233/ACP-2011-012",
language = "English",
volume = "34",
pages = "131--145",
journal = "Analytical Cellular Pathology",
issn = "2210-7177",
publisher = "IOS Press",
number = "3",

}

TY - JOUR

T1 - Targeting Glutathione-S transferase enzymes in musculoskeletal sarcomas

T2 - A promising therapeutic strategy

AU - Pasello, Michela

AU - Manara, Maria Cristina

AU - Michelacci, Francesca

AU - Fanelli, Marilù

AU - Hattinger, Claudia Maria

AU - Nicoletti, Giordano

AU - Landuzzi, Lorena

AU - Lollini, Pier Luigi

AU - Caccuri, Annamaria

AU - Picci, Piero

AU - Scotlandi, Katia

AU - Serra, Massimo

PY - 2011

Y1 - 2011

N2 - Recent studies have indicated that targeting glutathione-S-transferase (GST) isoenzymes may be a promising novel strategy to improve the efficacy of conventional chemotherapy in the three most common musculoskeletal tumours: osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma. By using a panel of 15 drug-sensitive and drug-resistant human osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma cell lines, the efficay of the GST-targeting agent 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) has been assessed and related to GST isoenzymes expression (namely GSTP1, GSTA1, GSTM1, and MGST). NBDHEX showed a relevant in vitro activity on all cell lines, including the drug-resistant ones and those with higher GSTs levels. The in vitro activity of NBDHEX was mostly related to cytostatic effects, with a less evident apoptotic induction. NBDHEX positively interacted with doxorubicin, vincristine, cisplatin but showed antagonistic effects with methotrexate. In vivo studies confirmed the cytostatic efficay of NBDHEX and its positive interaction with vincristine in Ewing's sarcoma cells, and also indicated a positive effect against the metastatisation of osteosarcoma cells. The whole body of evidence found in this study indicated that targeting GSTs in osteosarcoma, Ewing's sarcoma and rhabdomyosarcoma may be an interesting new therapeutic option, which can be considered for patients who are scarcely responsive to conventional regimens.

AB - Recent studies have indicated that targeting glutathione-S-transferase (GST) isoenzymes may be a promising novel strategy to improve the efficacy of conventional chemotherapy in the three most common musculoskeletal tumours: osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma. By using a panel of 15 drug-sensitive and drug-resistant human osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma cell lines, the efficay of the GST-targeting agent 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) has been assessed and related to GST isoenzymes expression (namely GSTP1, GSTA1, GSTM1, and MGST). NBDHEX showed a relevant in vitro activity on all cell lines, including the drug-resistant ones and those with higher GSTs levels. The in vitro activity of NBDHEX was mostly related to cytostatic effects, with a less evident apoptotic induction. NBDHEX positively interacted with doxorubicin, vincristine, cisplatin but showed antagonistic effects with methotrexate. In vivo studies confirmed the cytostatic efficay of NBDHEX and its positive interaction with vincristine in Ewing's sarcoma cells, and also indicated a positive effect against the metastatisation of osteosarcoma cells. The whole body of evidence found in this study indicated that targeting GSTs in osteosarcoma, Ewing's sarcoma and rhabdomyosarcoma may be an interesting new therapeutic option, which can be considered for patients who are scarcely responsive to conventional regimens.

KW - glutathione metabolism

KW - Musculoskeletal sarcomas

KW - novel antitumour agents

KW - target therapies

UR - http://www.scopus.com/inward/record.url?scp=79960809400&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960809400&partnerID=8YFLogxK

U2 - 10.3233/ACP-2011-012

DO - 10.3233/ACP-2011-012

M3 - Article

C2 - 21673434

AN - SCOPUS:79960809400

VL - 34

SP - 131

EP - 145

JO - Analytical Cellular Pathology

JF - Analytical Cellular Pathology

SN - 2210-7177

IS - 3

ER -